EP0259425A1 - Protein preservation - Google Patents

Protein preservation

Info

Publication number
EP0259425A1
EP0259425A1 EP19870901561 EP87901561A EP0259425A1 EP 0259425 A1 EP0259425 A1 EP 0259425A1 EP 19870901561 EP19870901561 EP 19870901561 EP 87901561 A EP87901561 A EP 87901561A EP 0259425 A1 EP0259425 A1 EP 0259425A1
Authority
EP
European Patent Office
Prior art keywords
polyhydroxy compound
water
protein
process according
haemoglobin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870901561
Other languages
German (de)
French (fr)
Inventor
James Arthur Hayward
David Samuel Johnston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Vascular Devices Ltd
Original Assignee
Biocompatibles Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocompatibles Ltd filed Critical Biocompatibles Ltd
Publication of EP0259425A1 publication Critical patent/EP0259425A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length

Definitions

  • the present invention relates to a method of dry storage which now permits the long-term preservation of materials such as haemoglobin, erythrocyes, liposomes and cells.
  • Oxidation of the iron atom of the haem prosthetic group from 2+ to the 3+ state converts oxy- or deoxyhaemoglobin to the biologically nonfunctional methaemoglobin.
  • the reaction is promoted by conditions of low oxygen tension and is minimised i n vivo by the presence of potent reducing systems operating in the cytoplasm of intact erythrocytes.
  • erythrocytes are obtained from human donors for transfusion, their storage ex vivo is limited, in part, by the accelerated formation of oxidised haem (methaemoglobin).
  • the present invention therefore provides a process for preserving a material having a water-dependant structure comprising contacting the material with an aqueous solution of a polyhydroxy compound then removing water from the material.
  • material having a water-dependant structure it is intended to encompass such materials as proteins, liposomes and cells which have secondary, tertiary or quaternary structure determined by hydrophobic and/or hydrophilic interactions in the presence of water which structure is irreversibly altered or partially or completely destroyed by removal of the water.
  • polyhydroxy compound it is intended to encompass any material having two or more hydroxy groups per molecule which is capable of hydrogen bonding to, or otherwise stabilising, a material having a water-dependant structure.
  • Suitable polyhydroxy compounds include sugars and similar or related polyols, especially trioses, pentoses and hexoses, mono-, di or oligosaccharides and related polyols.
  • Preferred polyhydroxy compounds are glucose, galactose and non-reducing sugars especially trehalose.
  • the present invention in a particular embodiment also provides a process for preserving a material having a water-dependant structure which encapsulates one or more spaces containing aqueous solutions or suspensions which comprises contacting the material with, and introducing into one or more encapsulated spaces therein, an aqueous solution of polyhydroxy compound then removing water from the material.
  • the present invention in another aspect provides a dry formulation comprising a material having a water-dependant structure and a polyhydroxy compound.
  • the polyhydroxy compound will be in intimate admixture with the material having a water-dependant structure and, in the case where the material encapsulates one or more spaces containing the residue of aqueous solutions or suspensions, preferably the polyhydroxy compound is also dispersed within those spaces.
  • the preservation process of the present invention is particularly suitable for the storage of haemoglobin with minimal oxidation of the heme-iron and with retention of gas-transporting capacity upon rehydration.
  • the dry haemoglobin may be prepared from simple aqueous solutions of purified haemoglobin, from erythrocyte lysates, from intact erythrocytes or from erythrocyte surrogates (haemosomes).
  • Hydrophobic structures such as the membranes which delimit all cells and their organelles, arise by the expulsion of water from their non-polar parts.
  • Hydrophilic structures such as globular proteins are stabilised by hydrogen-bonding with water in solution and by the maintenance of specific dipoles in a medium of specific dielectric constant.
  • anhydrobiosis In recent years the ability to survive desiccation, now termed “anhydrobiosis”, has been shown to be a property of a small but diverse group of organisms including fungal spores, macrocysts of the slime mold Dictyostelium, baker's yeast, brine shrimp cysts, nematodes and plant seeds (for review see Crowe and Crowe, 1984) .
  • Trehalose a non-reduc ing d isacchar ide of glucose that is distributed widely in nature, has been found at particularly high concentrations (as much as 20% of the dry weight) in several of the organisms capable of anhydrobiosis.
  • the survival of dehydration by some organisms is correlated with the synthesis of trehalose during dehydration (Madin and Crowe, 1975) or its degradation following rehydration (Clegg. 1964).
  • This molecule was implicated in the "water replacement hypothesis", which suggested that the hydroxyl groups of simple carbohydrates might replace the hydration shell of the polar head groups of phosopholipids that is lost during dehydration (Crowe and Clegg, 1973) .
  • a particularly novel extension of our invention concerns the stabilisation of dehydrated cells and their surrogates. It is possible to transiently produce pores in both biological and artificial membrane which spontaneously reseal. During the time course of their existence. however, these pores are of sufficient diameter to permit the entry of carbohydrates into the cytoplasm (cells) or encapsulated volume (liposomes). Thus, it should be possible to introduce trehalose (or other carbohydrates) into the cytoplasm of human erythrocytes, enabling their extended storage in the dehydrated state. Autologous red cells could therefore be stored indefinitely for patients at high risk of anaemia. Similarly, haemosomes could be prepared and stored in bulk following dehydration. Application of dry haemosomes would be a simple matter following their rehydration ad hoc.
  • Fig. 1 is a histogram showing Percentages of methaemoglobin formed upon rehydration of haemoglobin powders. Sugars were present at concentrations of 0.25 molar following rehydration; haemoglobin was 0.015 molar.
  • Oxyhaemoglobin without sugar 2) Deoxyhaemoglobin without sugar, and 3) to 11) Oxyhaemoglobin with 3) Arabinose, 4) Glactose, 5) Fucose, 6) Glucose, 7) Mannose, 8) Maltose, 9) lactose, 10) Trehalose and 11) Sucrose.
  • Carbohydrate-protein mixtures were prepared in solution by addition of carbohydrate to the protein dissolved in water or buffer. A variety of trioses, pentoses and hexoses were examined as well as mono- and disacchar ides. Concentrations of the sugars were varied, from 1:1 (weightrweight) up to a maximum of 0.25 molar sugar.
  • Water was removed by one of three methods: a) evaporation, in which the solution is mildly heated under a steady stream of gaseous nitrogen; b) evacuation, in which the sample is exposed to reduced pressure at room temperature, or, c) lyophilisation, in which the solution is first frozen in liquid nitrogen and the water sublimed under high vacuum. Dried samoles were stored for extended period over phosphorus pentoxide in vacuo.
  • Calorimetric evaluation was performed by differential scanning calorimetry (DSC) using Perkin-Elmer DSC-2.
  • the heating rate was 2.5°C/minute and a full-scale deflection on the recorder corresponded to a change in heat flow of 0.25m.cal./sec.
  • the transition temperatures obtained were the temperatures of maximal heat flow.
  • Table 1 contains the denaturation temperatures and denaturation enthalpy and entropy changes of lysozyme dissolved in water and in solutions of either of the sugars glucose, galactose or trehalose.
  • the presence of any of the three sugars increases the denaturation temperature, in general agreement with the observations reported by others (Gerlsma, 1968; Neucere and St. Angelo, 1972).
  • the sugars stabilise the native structure of the protein with respect to the denatured state. This property is exhibited by each of the three sugars examined.
  • the temperatures of maximum heat flow and the enthalpy and entropy changes associated with the transitions for freeze-dried lysozyme in the presence or absence of carbohydrate are outlined in Table 2.
  • the endothermic transition of pure dry lysozyme occurs at a temperature approximately 70°C above the denaturation temperature of the protein in water. In the solid state the polypeptide chains of a protein will be less flexible than in solution at the same temperature.
  • a dry protein will reach the degree of flexibility necessary for unfolding of the protein structure at a higher temperature than a protein in aqueous solution.
  • each of the carbohydrates tested was capable of protecting haemoglobin against oxidative damage.
  • the protective effect was clearly manifest even in those samples that had been stored in the dried state for periods in excess of three months.
  • Rehydrated sugar-haemoglobin mixtures were capable of reversible gas exchange as evidenced by the spectral shifts induced by exposure to oxygen, nitrogen or carbon monoxide.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un procédé de conservation d'un matériau ayant une structure hydrosensible consiste à mettre le matériau en contact avec une solution aqueuse d'un composé de polyhydroxy, puis à retirer l'eau du matériau.A method of preserving a material having a water-sensitive structure includes contacting the material with an aqueous solution of a polyhydroxy compound, and then removing water from the material.

Description

PROTEIN PRESERVATION
The present invention relates to a method of dry storage which now permits the long-term preservation of materials such as haemoglobin, erythrocyes, liposomes and cells.
Oxidation of the iron atom of the haem prosthetic group from 2+ to the 3+ state converts oxy- or deoxyhaemoglobin to the biologically nonfunctional methaemoglobin. The reaction is promoted by conditions of low oxygen tension and is minimised i n vivo by the presence of potent reducing systems operating in the cytoplasm of intact erythrocytes. When erythrocytes are obtained from human donors for transfusion, their storage ex vivo is limited, in part, by the accelerated formation of oxidised haem (methaemoglobin).
Storage in the dry state limits hydrolysis and prevents some of the oxidative damage that can destroy chemical or biological activity. When dealing with biological macromolecules, however, water removal can irreversibly alter secondary, tertiary or quaternary structures and thereby eliminate biological efficacies.
Dehydration of biological membranes is usually accompanied by irrevocable loss of structural and functional integrity (Crowe, Crowe and Jackson, 1983). Upon rehydration of biological membranes morphological damage is apparent in the redistribution of intramembraneous particles and the fusion between membranes. Moreover, in those membrane systems that are associated with a specific enzyme activity (such as the transport of Ca++) , rehydration induces a complete loss of activity.
Artificial membrane systems prepared by dispersion of phospholipids in aqueous solutions, have received much attention because of their utility in basic research and their potential applications in biotechnology. Dispersions of phospholipids spontaneously form sealed structures called liposomes - the encapsulated volume within a liposome enables the liposome to function as a pharmacological "capsule" or artificial cell. Among the solutes that have been encaosulated in liposomes is human haemoglobin. The "haemosomes" so generated hold much utilitarian promise as erythrocyte surrogates (Djordjevich and Miller, 1980; Gaber et al., 1983; Hayward et al., 1985) . However when liposomes containing entrapped solutes are subjected to dehydration/rehydration, the solutes are lost to the bulk solution (Madden et al., 1985).
The effect of encapsulation of haemoglobin within a phospholipid liposome was to catalyze the oxidation of haemoglobin upon rehydration. No oxyhaemoglobin could be regenerated from rehydrated haemosomes. Moreover, much of the visible absorbance of the rehydrated samples was bleached, resulting in essentially colourless samples. These observations are similar to those described by Szebeni et al. (1985), who found that unsaturated phospholipids promoted haemoglobin oxidation and were capable of extracting the haem away from the globin portion of the molecule.
We have found that by drying proteins from aqueous solutions containing saccharides, chemical and physical degradative processes can be avoided. If the carbohydrate selected is itself a solid, then a compact, solid protein-carbohydrate mixture is obtained which can be repeatedly cooled below 0ºC and warmed to room temperature without diminishing enzyme activity. Moreover this technique may be extended to facilitate storage of other materials having water-dependant structure such as liposomes and even intact cells.
We have examined the ability of trehalose and other sugars to preserve after dehydration/rehydration the biological activity of isolated proteins, protein systems, biological and artificial membranes, and whole cells.
The present invention therefore provides a process for preserving a material having a water-dependant structure comprising contacting the material with an aqueous solution of a polyhydroxy compound then removing water from the material.
By "material having a water-dependant structure" it is intended to encompass such materials as proteins, liposomes and cells which have secondary, tertiary or quaternary structure determined by hydrophobic and/or hydrophilic interactions in the presence of water which structure is irreversibly altered or partially or completely destroyed by removal of the water.
By "polyhydroxy compound" it is intended to encompass any material having two or more hydroxy groups per molecule which is capable of hydrogen bonding to, or otherwise stabilising, a material having a water-dependant structure. Suitable polyhydroxy compounds include sugars and similar or related polyols, especially trioses, pentoses and hexoses, mono-, di or oligosaccharides and related polyols. Preferred polyhydroxy compounds are glucose, galactose and non-reducing sugars especially trehalose.
The present invention, in a particular embodiment also provides a process for preserving a material having a water-dependant structure which encapsulates one or more spaces containing aqueous solutions or suspensions which comprises contacting the material with, and introducing into one or more encapsulated spaces therein, an aqueous solution of polyhydroxy compound then removing water from the material.
The present invention in another aspect provides a dry formulation comprising a material having a water-dependant structure and a polyhydroxy compound. The polyhydroxy compound will be in intimate admixture with the material having a water-dependant structure and, in the case where the material encapsulates one or more spaces containing the residue of aqueous solutions or suspensions, preferably the polyhydroxy compound is also dispersed within those spaces.
The preservation process of the present invention is particularly suitable for the storage of haemoglobin with minimal oxidation of the heme-iron and with retention of gas-transporting capacity upon rehydration. The dry haemoglobin may be prepared from simple aqueous solutions of purified haemoglobin, from erythrocyte lysates, from intact erythrocytes or from erythrocyte surrogates (haemosomes).
Whilst not wishing to be bound by any theory it is postulated that the stabilisation afforded according to the present invention may be related to that observed in certain instances of "anhydrobiosis".
The organisation of many biological structures depends absolutely upon the presence of water. Hydrophobic structures, such as the membranes which delimit all cells and their organelles, arise by the expulsion of water from their non-polar parts. Hydrophilic structures such as globular proteins are stabilised by hydrogen-bonding with water in solution and by the maintenance of specific dipoles in a medium of specific dielectric constant.
Some organisms, however, possess a remarkable capacity to survive near-total dehydration, and they may exist in the dehydrated states for periods measured in years. This fact was recognised as long ago as the year 1800 when it was found that in a dried state tardigrades, small sand-living organisms, were able to withstand temperatures well below freezing and as hot as boiling water (Crowe and Clegg, 1973 and 1978). Normal metabolic processess resumed in these organisms within thirty minutes of their rehydration even after decades of dry storage.
In recent years the ability to survive desiccation, now termed "anhydrobiosis", has been shown to be a property of a small but diverse group of organisms including fungal spores, macrocysts of the slime mold Dictyostelium, baker's yeast, brine shrimp cysts, nematodes and plant seeds (for review see Crowe and Crowe, 1984) .
Trehalose, a non-reduc ing d isacchar ide of glucose that is distributed widely in nature, has been found at particularly high concentrations (as much as 20% of the dry weight) in several of the organisms capable of anhydrobiosis. The survival of dehydration by some organisms is correlated with the synthesis of trehalose during dehydration (Madin and Crowe, 1975) or its degradation following rehydration (Clegg. 1964). This molecule was implicated in the "water replacement hypothesis", which suggested that the hydroxyl groups of simple carbohydrates might replace the hydration shell of the polar head groups of phosopholipids that is lost during dehydration (Crowe and Clegg, 1973) .
Recent experiments using infrared spectroscopy (Crowe, Crowe and Chapman, 1984), have provided evidence that trehalose may substitute for water by forming hydrogen bonds with the head groups of phospholipid bilayers thereby stabilising membrane structure in the absence of water. Support for this model was obtained by Madden et al. (1985) who demonstrated that the integrity of unilamellar liposomes is retained (i.e. no leakage of solute from the internal aqueous compartment of the liposome) if dehydration is carried out in the presence of carbohydrate. This protective capacity was shared among all of the carbohydrates tested.
Sugars and similar poly alcohols have been utilised in solution to preserve enzymatic activities (Bradbury and Jakoby, 1972) , inhibit irreversible aggregation (Frigon and Lee, 1972) and increase the temperature at which proteins are thermally denatured (Gerlsma, 1968; Neucere and St. Angelo, 1972).
Due to the widespread use of proteins in analytical, synthetic and biological chemistry, we envisage that carbohydrate-mediated protection of dried proteins will have many applications. The storage stability of most proteins should be enhanced by the processes we describe.
A particularly novel extension of our invention concerns the stabilisation of dehydrated cells and their surrogates. It is possible to transiently produce pores in both biological and artificial membrane which spontaneously reseal. During the time course of their existence. however, these pores are of sufficient diameter to permit the entry of carbohydrates into the cytoplasm (cells) or encapsulated volume (liposomes). Thus, it should be possible to introduce trehalose (or other carbohydrates) into the cytoplasm of human erythrocytes, enabling their extended storage in the dehydrated state. Autologous red cells could therefore be stored indefinitely for patients at high risk of anaemia. Similarly, haemosomes could be prepared and stored in bulk following dehydration. Application of dry haemosomes would be a simple matter following their rehydration ad hoc.
The invention will now be illustrated by non-limiting Examples and with reference to the accompanying drawings in which; Fig. 1 is a histogram showing Percentages of methaemoglobin formed upon rehydration of haemoglobin powders. Sugars were present at concentrations of 0.25 molar following rehydration; haemoglobin was 0.015 molar. 1) Oxyhaemoglobin without sugar, 2) Deoxyhaemoglobin without sugar, and 3) to 11) Oxyhaemoglobin with 3) Arabinose, 4) Glactose, 5) Fucose, 6) Glucose, 7) Mannose, 8) Maltose, 9) lactose, 10) Trehalose and 11) Sucrose.
EXAMPLES 1 AND 2
Different sugars are utilised to produce dry powders of two separate proteins, chicken egg-white lysozyme (Example 1) and human haemoglobin (Examole 2) . Structural stability was examined by calorimetry of the wet and dry lysozyme preparations. Functional stability was verified by spectroscopic evaluation of gas transport by haemoglobin.
Carbohydrate-protein mixtures were prepared in solution by addition of carbohydrate to the protein dissolved in water or buffer. A variety of trioses, pentoses and hexoses were examined as well as mono- and disacchar ides. Concentrations of the sugars were varied, from 1:1 (weightrweight) up to a maximum of 0.25 molar sugar.
Water was removed by one of three methods: a) evaporation, in which the solution is mildly heated under a steady stream of gaseous nitrogen; b) evacuation, in which the sample is exposed to reduced pressure at room temperature, or, c) lyophilisation, in which the solution is first frozen in liquid nitrogen and the water sublimed under high vacuum. Dried samoles were stored for extended period over phosphorus pentoxide in vacuo.
Calorimetric evaluation was performed by differential scanning calorimetry (DSC) using Perkin-Elmer DSC-2. The heating rate was 2.5°C/minute and a full-scale deflection on the recorder corresponded to a change in heat flow of 0.25m.cal./sec. The transition temperatures obtained were the temperatures of maximal heat flow.
Table 1 contains the denaturation temperatures and denaturation enthalpy and entropy changes of lysozyme dissolved in water and in solutions of either of the sugars glucose, galactose or trehalose. The presence of any of the three sugars increases the denaturation temperature, in general agreement with the observations reported by others (Gerlsma, 1968; Neucere and St. Angelo, 1972). Hence, in solution, the sugars stabilise the native structure of the protein with respect to the denatured state. This property is exhibited by each of the three sugars examined.
The temperatures of maximum heat flow and the enthalpy and entropy changes associated with the transitions for freeze-dried lysozyme in the presence or absence of carbohydrate are outlined in Table 2. The endothermic transition of pure dry lysozyme occurs at a temperature approximately 70°C above the denaturation temperature of the protein in water. In the solid state the polypeptide chains of a protein will be less flexible than in solution at the same temperature.
Therefore, a dry protein will reach the degree of flexibility necessary for unfolding of the protein structure at a higher temperature than a protein in aqueous solution.
In the presence of sugar, the transition temperature is decreased, and the enthalpy and entropy changes for the transition equal or exceed those values seen for the protein in solution. Thus, it is apparent that as the water of hydration is removed from the surface of the protein, it is gradually replaced by sugar, resulting in a stabilisation of protein conformation that does not occur in the absence of added sugar.
Although each of the three sugars studied was capable of restoring the calorimetric behaviour of dissolved lysozyme to the dried protein, it was observed that the heated powders containing glucose or galactose were "browned". This browning reaction did not occur in the presence of trehalose. Thus, the selective pressure toward the occurrence of trehalose in anhydrobiotic organisms may be due less to its capcity to substitute for water than to its non-reducing characteristics which prevent the browning reaction. Nonetheless, in our invention any of the above-mentioned sugars are appropriate for storage of dry protein-sugar mixtures.
These results were extended by determinations of the functional integrity of a human haemoglobin before and after dehydration/rehydration in the presence or absence of various carbohydrates. The relative concentrations of oxy-, deoxy- and methaemoglobins were calculated from the spectra obtained in solution according to the methods described in Benesch et al. (1965). In Figure 1 are presented the percentages of methaemoglobin formed in solutions of human haemoglobin following a cycle of dehydration/rehvdration. When dried haemoglobin without sugar was rehydrated, the solution assumed the brown colour characteristic of methaemoglobin. The percentage of methaemoglobin formed increased with the duration of storage, up to 90% of the total haem. Similar spectra could be generated by catalytic oxidation of the haem after addition of potassium ferricyanide.
In strong contrast to the behaviour of rehydrated haemoglobin in the absence of sugar, each of the carbohydrates tested was capable of protecting haemoglobin against oxidative damage. The protective effect was clearly manifest even in those samples that had been stored in the dried state for periods in excess of three months. Rehydrated sugar-haemoglobin mixtures were capable of reversible gas exchange as evidenced by the spectral shifts induced by exposure to oxygen, nitrogen or carbon monoxide.
Together, our results obtained with dried powders of lysozyme or haemoglobin demonstrate that carbohydrates enhance the stability of anhydrous proteins and permit the retention of physicochemical and biological activities after rehydration.
EXAMPLE 3
Our previous investigations of hemosomes as erythrocyte surrogates (Hayward et al., 1985) in combination with our demonstration of protein stabilisation in the dry state by carbohydrate, prompted us to examine the capacity of sugars to stabilize artificial red blood cells in the dry state. We reasoned that the protective capacity of carbohydrate in this instance should be bimodal - prevention of the oxidation and denaturation of haemoglobin and the simultaneous retention of encapsulated haemoglobin within the internal aqueous compartment of the haemosome.
We found that inclusion of carbohydrates (both within the haemosome and in the external, bulk solution) prevented haem oxidation. Furthermore, rehydrated carbohydrate/haemosomes could be passed through a molecular sieve without diminution in the ratio of haemoglobin: phospholipid. All of the carbohydrates tested to-date have been effective in this capacity. Conversely, carbohydrate-free haemosomes became irreversibly aggregated and the phospholipid was readily separated from haemoglobin due to the former's relative buoyancy.
LITERATURE CITED
Benesch, R. , MacDuff, G. and Benesch, R.E/ (1965) Anal Biochem 11: 81 - 87.
Bradbury, S.L. and Jakoby, W.B. (1972) Glycerol as an enzyme-stabilizing agent: effects on aldehyde dehydrogenase, Proc. Nat Acad Sci 69: 2373 - 2376. Clegg, J.S. (1964) The control of emergence and metabolism by external osmotic pressure and the role of free glycerol in developing cysts of Artneia salina, J. Exp Biol 41 : 879 - 892.
Crowe, J.H. and Clegg, J.S. (1973) "Anhydrobiosis:, Dowden, Hutchinson and Ross, Stroudsburg, P.A. p. 473. Crowe, J.H, and Clegg, J.S. (1978) "Dry Biological Systems", Academic Press, NY, p. 357. Crowe, J.H, Crowe, L.M. and Jackson S.A. (1983) Preservation of structural and functional activity in lyophilised sarcoplasmic reticulum. Arch Biochem Biophys. 220: 477 - 484.
Crowe, L.M. and Crowe, J.H. (1984) Effects of dehydration on membranes and membrane stabilisation at low water activities, in Chapman, D. , ed., "Biological Membranes", Volume 5, Academic Press, London, pp. 57 - 102. Crowe J.H., Crowe, L.M. and Chapman, D. (1984) Preservation of membranes in anhydrobiotic organisms: the role of trehalose. Science 223: 701 - 703. Djordjevich, L. and Miller, I.F. (1980) Synthetic erythrocytes from lipid encapsulated hemoglobin, Exp. Hematol. 8: 584 -592.
Frigon, R.P. and Lee, J.C. (1972) The stabilization of calf-brain microtubule protein by sucrose. Arch. Biochem Biophys 153: 587 - 589.
Gaber , B., Yager, P., Sheridan, J.P. and Chang, E.L,. (1983) Encapsulation of hemoglobin in phospholipid vesicles, FEBS Lett. 153: 285 - 288. Gerlsma, S.Y. (1968) J. Biol Chem 243: 957 - 963. Hayward, J.A. Levine, D.M., Neufeld, L. , Simon, S.R. , Johnston, D.S. and Chapman D. (1985) Polymerized liposomes as stable oxygen-carriers, FEBS Lett 187: 261 - 266. Madden, T.D., Bally, M.B., Hope, M.J., Cullis, P.R., Schieren, H.P. and Janoff, A.S. (1985) Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicles contents, Biochem. Biophys Acta 817: 67 - 74.
Madin, K.A.C. and Crowe, J.H. (1975) Anhydrobiosis in nematodes: carbohydrate and lipid metabolism during dehydration. J. Exp. Zool. 193: 335 - 342. Neucere, N.J. and St. Angelo, A.J. (1972) Physicochemical properties of peanut proteins in sucrose. Anal Biochem. 47: 80 - 89.
Szebeni, J., Di Iorio, E.E., Hauser, H. and Winterhalter, K.H. (1985) Encapsulation of hemoglobin in phospholipid vesicles: characterization and stability. Biochemistry 24: 2827 - 2832.

Claims

1. A process for preserving a material having water-dependant structure comprising contacting the material with an aqueous solution of a polyhydroxy compound then removing water from the material.
2. A process according to claim 1 wherein the material is a protein, liposome or cell.
3. A process according to claim 1 wherein the material is an erythrocyte, oxyhaemaglobin, deoxyhaemaglobin or liposomes encapsulating oxyhaemaglobin or deoxyhaemaglonin.
4. A process according to claim 1 wherein the material encapsulates one or more spaces containing aqueous solutions or suspensions and wherein the process comprises contacting the material with, and introducing into one of more encapsulated spaces therein, an aqueous solution of a polyhydroxy compound then removing water from the material.
5. A process according to claim 1 wherein the polyhydroxy compound is a sugar or related polyol.
6. A process according to claim 5 wherein the polyhydroxy compound is selected from trioses, pentoses, hexoses, mono-, di- or oligosaccharides and related polyols.
7. A process according to claim 6 wherein the polyhydroxy compound is selected from glucose, galactose and non-reducing sugars.
8. A process according to claim 7 wherein the polyhydroxy compound is trehalose.
9. A dry formulation comprising a material having a water-dependant structure and a polyhydroxy compound in intimate admixture therewith.
10. A formulation according to claim 9 wherein the material is a protein, liposome or cell.
11. A formulation according to claim 9 wherein the material is an erythrocyte, oxyhaemaglobin, deoxyhaemaglobin or liposomes encapsulating oxyhaemaglobin or deoxyhaemaglobin.
12. A formulation according to claim 9 wherein the material encapsulates one or more spaces containing aqueous solutions or suspensions.
13. A formulation according to claim 9 wherein the polyhydroxy compound is a sugar or related polyols.
14. A formulation according to claim 13 wherein the polyhydroxy compound is selected from trioses, pentoses, hexoses, mono-, di- or oligosaccharides and related polyols.
15. A formulation according to claim 14 wherein the polyhydroxy compound selected from glucose, galactose and non-reducing sugars.
16. A formulation according to claim 15 wherein the polyhydroxy compound is trehalose.
EP19870901561 1986-02-28 1987-02-27 Protein preservation Withdrawn EP0259425A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868604983A GB8604983D0 (en) 1986-02-28 1986-02-28 Protein preservation
GB8604983 1986-02-28

Publications (1)

Publication Number Publication Date
EP0259425A1 true EP0259425A1 (en) 1988-03-16

Family

ID=10593832

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870901561 Withdrawn EP0259425A1 (en) 1986-02-28 1987-02-27 Protein preservation

Country Status (4)

Country Link
EP (1) EP0259425A1 (en)
JP (1) JPS63502592A (en)
GB (1) GB8604983D0 (en)
WO (1) WO1987005300A2 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8715238D0 (en) * 1987-06-29 1987-08-05 Quadrant Bioresources Ltd Food process
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
US5958670A (en) * 1988-05-18 1999-09-28 Cobe Laboratories, Inc. Method of freezing cells and cell-like materials
EP0437479B1 (en) * 1988-10-05 1994-06-22 Vestar, Inc. Method of making liposomes with improved stability during drying
US5059518A (en) * 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same
US5192663A (en) * 1988-11-04 1993-03-09 Immucor, Inc. Article having an organic dye and a monolayer of dried mammalian cells and a method for utilizing the article
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
USRE38385E1 (en) 1989-02-16 2004-01-13 Nektar Therapeutics Storage of materials
GB8903593D0 (en) 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
FR2645741B1 (en) * 1989-03-20 1995-06-23 Dior Christian Parfums PROCESS FOR FIXING A PRODUCT ON THE MEMBRANE OF A KERATINOCYTE BY MEANS OF A LIGAND-RECEPTOR BINDING, PROCESS FOR PREPARING SUCH A PRODUCT, PRODUCT OBTAINED, COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR PREPARING THE SAME
ZA902663B (en) * 1989-04-07 1991-12-24 Syntex Inc Interleukin-1 formulation
US5384132A (en) * 1990-03-20 1995-01-24 Akzo N.V. Stabilized gonadotropin containing preparations
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
CA2075928A1 (en) * 1991-01-11 1992-07-12 Roger W. Hackett Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material
AU659645B2 (en) 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
AU672775B2 (en) * 1992-01-21 1996-10-17 Cobe Laboratories Inc. Method of freezing cells and cell-like materials
EP0686045B1 (en) * 1993-02-23 2000-11-15 Genentech, Inc. Excipient stabilization of polypeptides treated with organic solvents
EP0615747B1 (en) 1993-03-18 1999-09-29 Terumo Kabushiki Kaisha Hemoglobin-encapsulating liposome and method for making the same
US5674528A (en) * 1994-06-15 1997-10-07 Terumo Kabushiki Kaisha Hemoglobin-encapsulated liposome
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6309671B1 (en) 1995-04-14 2001-10-30 Inhale Therapeutic Systems Stable glassy state powder formulations
GB9508691D0 (en) 1995-04-28 1995-06-14 Pafra Ltd Stable compositions
WO1996040077A2 (en) * 1995-06-07 1996-12-19 Quadrant Holdings Cambridge Limited Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
DK0967862T3 (en) 1997-02-07 2003-05-12 Elan Drug Delivery Ltd Methods and compositions for preparing dried, storage-stable platelets
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6770478B2 (en) 2000-02-10 2004-08-03 The Regents Of The University Of California Erythrocytic cells and method for preserving cells
WO2001058266A1 (en) 2000-02-10 2001-08-16 The Regents Of The University Of California Therapeutic platelets and methods
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
AU2003278166B2 (en) * 2002-11-01 2009-01-29 Glaxosmithkline Biologicals S.A. Immunogenic composition
ES2502691B1 (en) * 2013-09-25 2015-07-07 Sani-Red, S.L. Protein preservation and stabilization method, applicable for industrial developments of medical, pharmaceutical and cosmetic formulations
WO2016209907A1 (en) 2015-06-25 2016-12-29 The Regents Of The University Of California Stable support films for electron microscopy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1855591A (en) * 1926-02-03 1932-04-26 Wallerstein Co Inc Invertase preparation and method of making the same
EP0111216A3 (en) * 1980-03-31 1985-01-16 Takeda Chemical Industries, Ltd. Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
AU587600B2 (en) * 1985-01-11 1989-08-24 Regents Of The University Of California, The Method for preserving liposomes
JPH0779694B2 (en) * 1985-07-09 1995-08-30 カドラント バイオリソ−シズ リミテツド Protection of proteins and similar products

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8705300A2 *

Also Published As

Publication number Publication date
WO1987005300A2 (en) 1987-09-11
WO1987005300A3 (en) 1987-10-22
JPS63502592A (en) 1988-09-29
GB8604983D0 (en) 1986-04-09

Similar Documents

Publication Publication Date Title
EP0259425A1 (en) Protein preservation
Farmer et al. [18] Liposome-encapsulated hemoglobin as an artificial oxygen-carrying system
US5242792A (en) Method for the preservation of red blood cells by lyophilization using glycerol or inositol with disaccharides
JP2809735B2 (en) Lyophilization of cells
US4806343A (en) Cryogenic protectant for proteins
CA1197462A (en) Functional oxygen transport system
US4874690A (en) Lyophilization of red blood cells
US5178884A (en) Lyophilized and reconstituted red blood cell compositions
Crowe et al. Stabilization of dry phospholipid bilayers and proteins by sugars.
KR920002300B1 (en) Method for preserving liposomes
US5043261A (en) Lyophilized and reconstituted red blood cell and hemosome compositions
IE47165B1 (en) Process for the dehydration of a colloidal dispersion of liposomes
US5690963A (en) Freeze dried red blood cells
US4897353A (en) Cryogenic protection of phosphofructokinase using amino acids and zinc ions
Török et al. Preservation of trehalose-loaded red blood cells by lyophilization
Tan et al. Freeze-drying of fungi: influence of composition and glass transition temperature of the protectant
ES2210481T3 (en) THERMOSTABILIZATION, OSMOPROTECTION AND PROTECTION AGAINST THE DESECTION OF ENZYMES, CELL COMPONENTS AND CELLS THROUGH MANOSILGLYCERATE.
Yoshikawa et al. Extraction of trehalose from thermally-treated bakers’ yeast
CN102327289B (en) Erythrocyte freeze-dried powder preparation for injection and preparation method thereof
Meldrum The reduction of glutathione in mammalian erythrocytes
EP0955991B1 (en) Lecithin-based microemulsions containing proteolytic enzymes and method for permanent enzymic depilation
US4612370A (en) Lipid-saccharide reaction products
Johnston et al. The influence of sugars on the properties of freeze-dried lysozyme and haemoglobin
WO1992008478A1 (en) Method of enhancing long-term storage stability of hemoglobin products
US4954354A (en) Process utilizing alcohol oxidase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19871117

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19900514

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19900925

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HAYWARD, JAMES, ARTHUR

Inventor name: JOHNSTON, DAVID, SAMUEL